Zdrowie i gospodarka · 30/12/2011

FDA Releases Draft Guidance on Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices

The Food and Drug Administration (FDA) has published a draft guidance document outlining its policies for responding to unsolicited requests for off-label information about prescription drugs and medical devices, aiming to clarify and update its current views on the matter.